Articles

The American Society of Cataract and Refractive Surgery hosted its 2021 ASCRS and ASOA Annual Meeting July 23-27 in Las Vegas, Nevada.

ASCRS conference overview for retina specialists

Videos

Following a discussion regarding drug delivery challenges in retinal disease, a panel of global experts suggest what types of technological requirements and improvements they would like to see occur in the field.

Addressing Drug Delivery Gaps in Retinal Disease

Challenges associated with delivering therapies currently available to treat retinal disorders and methods being explored to improve drug delivery to patients.

Drug Delivery Challenges in Retinal Disease

Nanoscope Therapeutics Inc. has dosed its first patient in a late-stage Phase 2b trial of a gene therapy that delivers multi-characteristic opsin to retinal cells.

Optogenetic gene therapy trial begins, first patient dosed

Mark Breazzano, MD, discusses the effects of the COVID-19 pandemic on daily practice for retina specialists.

How has the COVID-19 pandemic affected daily practice for retina specialists?

A team of investigators found that the retina may offer signs of COVID-19 infection before symptoms present.

First signs of COVID-19 seen in the retina, investigators report

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Why investigators are considering AMD to be a disease spectrum rather than a single disease.

Gaining a greater understanding of AMD

With orphan drug and fast track status, Neurotech plans to seek FDA approval for its NT-501 Implant platform late next year.

Encapsulated cell technology delivery of ciliary neurotrophic factor: promising treatment for macular telangiectasia type 2

Investigators have found that 78% of neovascular AMD cases have been detected using the PHP home monitoring system.

Home monitoring patients for AMD: Targeting CNV

A team of investigators used corneal confocal microscopy to identify corneal nerve damage in cases of long COVID-19.

Encapsulated cell technology delivery of ciliary neurotrophic factor: promising treatment for macular telangiectasia type 2

Home monitoring patients for AMD: Targeting CNV

Research suggests link between long COVID-19 and corneal nerve damage